Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study ; volume:39 ; number:1 ; day:22 ; month:11 ; year:2021 ; pages:562-582 ; date:1.2022
Advances in therapy ; 39, Heft 1 (22.11.2021), 562-582, 1.2022
- Urheber
-
Kelton, Kari
Klein, Tim
Murphy, Dan
Belger, Mark
Hille, Erik
McCollam, Patrick L.
Spiro, Theodore
Burge, Russel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-021-01982-6
- URN
-
urn:nbn:de:101:1-2022050720235158131191
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kelton, Kari
- Klein, Tim
- Murphy, Dan
- Belger, Mark
- Hille, Erik
- McCollam, Patrick L.
- Spiro, Theodore
- Burge, Russel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
Remdesivir: A Review in COVID-19
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
Remdesivir: A Review in COVID-19
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience
Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review
Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
Outcomes Among Patients Hospitalized for COVID-19 Treated with Remdesivir in an Urban Center Pre-COVID-19 Vaccination
Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
Remdesivir: A Review in COVID-19
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab
Cost-Effectiveness Analysis of Remdesivir Treatment in COVID-19 Patients Requiring Low-Flow Oxygen Therapy: Payer Perspective in Turkey